top of page
Edinburgh Metabolism Logo

Understanding Mechanisms Maintaining Metabolic Health Across The Life Course

University of Edinburgh Logo

Our
Mission

Edinburgh Metabolism, within the Centre for Cardiovascular Science at the University of Edinburgh, brings together clinical and basic scientists focused on:

 

  • Understanding mechanisms maintaining metabolic health across the life course.

  • Understanding how these go awry to drive ill health, including obesity, diabetes, fatty liver, cardiovascular diseases, and increased susceptibility to infections.

  • Developing novel approaches to reducing disease risk and treating established metabolic disease.

  • Pioneering new approaches to enable cardiometabolic  science.


Our aim is to act as a nexus for cross-disciplinary collaborations positioned at the cutting edge of advances in understanding and treating cardiometabolic diseases.

QMRI.jpg

We maintain close collaborations across the University of Edinburgh, particularly through the Edinburgh Diabetes Network, and with the Institute for Regeneration and Repair, the Institute of Genetics and Cancer, The Usher Institute, Edinburgh Neuroscience, and the Edinburgh Pregnancy Research Team.  We benefit from a range of strong international collaborations, especially with Denmark (through the Danish Diabetes and Endocrine Academy, DDEA) and Malawi (through NIHR funding).


Our position in the Edinburgh BioQuarter campus seeds strong interactions with data scientists within the Usher Institute/DataLoch. Our wider outreach includes links with One Health programmes in the veterinary campus (e.g. LARIF) well as a strong interdisciplinary interface with physical science colleagues in the Kings Building Campus. 


In addition to CVS's wider seminar programme, Edinburgh Metabolism runs more thematically focused internal meetings, including a monthly Adipose Biology Club and a Steroid Interest Group. The UK-wide Adipose Tissue Discussion Group meetings in 2018, 2021 and 2023 were organised by our members. Our members also lead the Scottish Metabolomics Network. 


Our work enjoys broad-based support from numerous funders, including the British Heart Foundation, Diabetes UK, MRC, BBSRC, Wellcome Trust, the Chief Scientist Office, and the NIHR.

Our research encompasses a wide range of experimental approaches and modalities, including:


•    Cell and molecular biology
•    Advanced imaging and analytic platforms
•    Model organism genetics and physiology
•    Proof of concept for advanced therapies
•    Human genetics and epidemiology
•    Experimental medicine
•    Clinical trials
•    Data science

Our Funders & Partners

We appreciate the invaluable support of our funders, whose contributions enable ground-breaking research and initiatives to advance metabolic health and improve outcomes for affected individuals.

UK Research and Innovation
Diabetes UK
British Heart Foundation
Medical Research Scotland
Chief Science Officer
Wellcome
Heart Research UK
NovoNordisk.JPG
UKT1D Research Consortium.JPG
JDRF.JPG
Helmsley.JPG
T1D Grand Challenge.JPG
Edinburgh Lothians Health Foundation.JPG

Publications

Our most recent publications

Steroid hormone receptors in cardiometabolic disease.

Goodwin J, Odermatt A, Morgan R, Nixon M.

Front Endocrinol (Lausanne). 2023 Jul 19;14:1251897.

PMID: 37538788

The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action.

Devine K, Villalobos E, Kyle CJ, Andrew R, Reynolds RM, Stimson RH, Nixon M, Walker BR.

Nat Rev Endocrinol. 2023 Feb;19(2):112-124.

PMID: 36221036 

High salt intake activates the hypothalamic-pituitary-adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice.

Costello HM, Krilis G, Grenier C, Severs D, Czopek A, Ivy JR, Nixon M, Holmes MC, Livingstone DEW, Hoorn EJ, Dhaun N, Bailey MA.

Cardiovasc Res. 2023 Jul 6;119(8):1740-1750.

PMID: 36368681 

Corticosteroid-binding Globulin (SERPINA6) Establishes Postpubertal Sex Differences in Rat Adrenal Development.

Toews JNC, Philippe TJ, Hill LA, Dordevic M, Miguelez-Crespo A, Homer NZM, Nixon M, Hammond GL, Viau V.

Endocrinology. 2022 Oct 11;163(11):bqac152. 

PMID: 36112420

ABCC1 modulates negative feedback control of the hypothalamic-pituitary-adrenal axis in vivo in humans.

Kyle CJ, Nixon M, Homer NZM, Morgan RA, Andrew R, Stimson RH, Walker BR.

Metabolism. 2022 Mar;128:155118. 

PMID: 34990712

Media

bottom of page